Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Juan Li, Fanyue Meng, Jingshan Zheng, Qi Liang, Huayu Li, Jingxin Li, Li Zhang, Jianhui Gan & Fengcai Zhu. (2021) Immune persistence induced by three doses of 60 μg hepatitis B vaccine in non-responders following standard primary vaccination in Chinese adults. Human Vaccines & Immunotherapeutics 17:8, pages 2762-2767.
Read now
Read now
Zhigang Zheng, Guojian Li, Fuhui Liao, Lujuan Zhang, Xueyan Wang, Zhongliao Fang, Qinyan Chen, Huabin Liu & Liping Hu. (2021) Seroconversion of hepatitis B surface antigen among those with previously successful immune response in Southern China. Human Vaccines & Immunotherapeutics 17:3, pages 845-851.
Read now
Read now
Shabir A. Madhi, Pío López, Betzana Zambrano, Emilia Jordanov, Siham B’Chir, Fernando Noriega & Emmanuel Feroldi. (2019) Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration. Human Vaccines & Immunotherapeutics 15:3, pages 658-668.
Read now
Read now
Tino F. Schwarz, Ulrich Behre, Thomas Adelt, Matthias Donner, Pemmaraju V. Suryakiran, Winnie Janssens, Narcisa Mesaros & Falko Panzer. (2019) Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy. Human Vaccines & Immunotherapeutics 15:1, pages 235-241.
Read now
Read now
Wenlong Wu, Jingjing Lv, Jiaye Liu, Bingyu Yan, Yi Feng, Aiqiang Xu & Li Zhang. (2018) Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China. Human Vaccines & Immunotherapeutics 14:10, pages 2485-2490.
Read now
Read now
Zikang Wu, Jun Yao, Hongdan Bao, Yongdi Chen, Shunshun Lu, Jing Li, Linna Yang, Zhenggang Jiang, Jingjing Ren, Kai-jin Xu, Bing Ruan, Shi-gui Yang, Tian-sheng Xie & Qian Li. (2018) The effects of booster vaccination of hepatitis B vaccine on children 5–15 years after primary immunization: A 5-year follow-up study. Human Vaccines & Immunotherapeutics 14:5, pages 1251-1256.
Read now
Read now
Pope Kosalaraksa, Kulkanya Chokephaibulkit, Suwat Benjaponpitak, Chitsanu Pancharoen, Sunate Chuenkitmongkol, Siham B'Chir, Xavier Da Costa & Emmanuel Vidor. (2018) Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months. Human Vaccines & Immunotherapeutics 14:5, pages 1257-1265.
Read now
Read now
Luisa Romanò, Cristina Galli, Catia Tagliacarne, Maria Elena Tosti, Claudio Velati, Laura Fomiatti, Maria Chironna, Rosa Cristina Coppola, Mario Cuccia, Rossana Mangione, Fosca Marrone, Francesco Saverio Negrone, Antonino Parlato, Carla Maria Zotti, Alfonso Mele & Alessandro Remo Zanetti. (2017) Persistence of immunity 18–19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy. Human Vaccines & Immunotherapeutics 13:5, pages 981-985.
Read now
Read now
Pierre Van Damme, Geert Leroux-Roels, P. Suryakiran, Nicolas Folschweiller & Olivier Van Der Meeren. (2017) Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Human Vaccines & Immunotherapeutics 13:5, pages 972-980.
Read now
Read now
Zhen-Zi Wang, Yu-Hua Gao, Wei Lu, Cun-Duo Jin, Ying Zeng, Ling Yan, Feng Ding, Tong Li, Xue-En Liu & Hui Zhuang. (2017) Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China. Human Vaccines & Immunotherapeutics 13:4, pages 909-915.
Read now
Read now
Yongdi Chen, Huakun Lv, Hua Gu, Fujiang Cui, Fuzhen Wang, Jun Yao, Shichang Xia & Xiaofeng Liang. (2014) The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5–15 y after primary immunization; China, 2009–2010. Human Vaccines & Immunotherapeutics 10:2, pages 498-504.
Read now
Read now
Articles from other publishers (40)
Nasamon Wanlapakorn, Napa Pruetarat, Nasiri Sarawanangkoor, Kanchana Phanphanit, Donchida Srimuan, Thaksaporn Thatsanathorn, Thanunrat Thongmee, Nawarat Posuwan & Yong Poovorawan. (2023) Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age. Vaccine 41:26, pages 3855-3861.
Crossref
Crossref
Rogério Soares Castro, Bárbara Silva Cordeiro, Marco Aurélio Ferreira Rolim, Alessandra Porto de Macedo Costa, Max Diego Cruz Santos, Marcos Antonio Custódio Neto da Silva, Ingrid de Campos Albuquerque, Lena Maria Barros Fonseca, João Renato Rebello Pinho, Michelle Soares Gomes Gouvêa, Antônio Augusto Moura da Silva & Adalgisa de Souza Paiva Ferreira. (2023) High prevalence of hepatitis B virus and low vaccine response in children and adolescents in Northeastern Brazil. Revista do Instituto de Medicina Tropical de São Paulo 65.
Crossref
Crossref
John W. Ward, Nasamon Wanlapakorn, Yong Poovorawan & Daniel Shouval. 2023. Plotkin's Vaccines. Plotkin's Vaccines
389
432.e21
.
Belaynew W. Taye, Patricia C. Valery & Paul J. Clark. (2022) Targeted antiviral treatment of hepatitis B virus in culturally and linguistically diverse populations to achieve elimination targets in Australia. Journal of Viral Hepatitis 29:10, pages 868-878.
Crossref
Crossref
Engy Mohamed El-Ghitany, Ayat Ashour, Marwa M. Fekry, Ehab Elrewany, Azza Galal Farghaly & Eman A. Omran. (2022) Seroprevalence of Hepatitis A, B and C Among a Sample of Refugees in Egypt: An Exploratory Survey. Journal of Epidemiology and Global Health 12:4, pages 430-440.
Crossref
Crossref
Oyu-Erdene Shagdarsuren, Ser-Od Khuyag, Yerkyebulan Mukhtar, Undram Mandakh, Enkh-Oyun Tsogzolbaatar, Shatar Shaarii, Nyamsuren Batsuren, Bira Namdag, Otgonbayar Radnaa & Davaalkham Dambadarjaa. (2022) Post-vaccination Immunity Against Hepatitis B Among Mongolian Adolescents and Youths. Hepatitis Monthly 21:12.
Crossref
Crossref
Nanthida Phattraprayoon, Jirapa Kakheaw, Kamonwan Soonklang, Kunsuda Cheirsilpa, Teerapat Ungtrakul, Chirayu Auewarakul & Nithi Mahanonda. (2022) Duration of Hepatitis B Vaccine-Induced Protection among Medical Students and Healthcare Workers following Primary Vaccination in Infancy and Rate of Immunity Decline. Vaccines 10:2, pages 267.
Crossref
Crossref
Palittiya Sintusek, Kessarin Thanapirom, Piyawat Komolmit & Yong Poovorawan. (2022) Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030. World Journal of Gastroenterology 28:3, pages 290-309.
Crossref
Crossref
Mohammed A AlAteeq, Latifa M AlEnazi, Modhi S AlShammari, Essa E AlAnazi, Fadel H Al-Hababi & Abdulrahman M Alateeq. (2022) Long-term Immunity Against Hepatitis B Virus After Routine Immunization Among Adults Visiting Primary Care Centers in Riyadh, Saudi Arabia. Cureus.
Crossref
Crossref
Laura Cordeiro Gomes, Marina Cordeiro Gomes Sanson, Philip Brainin, Maria da Conceição Vieira de Melo, Rodrigo Medeiros de Souza, Janaína Mazaro, Karine Oliveira Lima, Júnia Silva Resende, Isabelle Victória Martins Vieira, Edinilson da Silva Mesquita, Luan Oliveira Matos, Isabelle Caroline Silva Dutra, Giuseppe Palmisano, Carsten Wrenger, Claudio Romero Farias Marinho & Rita do Socorro Uchôa da Silva. (2021) Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon. PLOS ONE 16:7, pages e0253752.
Crossref
Crossref
Sonia Budroni, Francesca Buricchi, Andrea Cavallone, Patricia Bourguignon, Magalie Caubet, Vincent Dewar, Ugo D’Oro, Oretta Finco, Nathalie Garçon, Mohamed El Idrissi, Michel Janssens, Geert Leroux-Roels, Arnaud Marchant, Tino Schwarz, Pierre Van Damme, Gianfranco Volpini, Robbert van der Most, Arnaud M. Didierlaurent & Wivine Burny. (2021) Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. npj Vaccines 6:1.
Crossref
Crossref
Laís Canniatti Brazaca, Pãmyla Layene dos Santos, Paulo Roberto de Oliveira, Diego Pessoa Rocha, Jéssica Santos Stefano, Cristiane Kalinke, Rodrigo Alejandro Abarza Muñoz, Juliano Alves Bonacin, Bruno Campos Janegitz & Emanuel Carrilho. (2021) Biosensing strategies for the electrochemical detection of viruses and viral diseases – A review. Analytica Chimica Acta 1159, pages 338384.
Crossref
Crossref
John W. Ward. 2021. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease
169
203
.
Nawarat Posuwan, Nasamon Wanlapakorn, Palittiya Sintusek, Rujipat Wasitthankasem, Kittiyod Poovorawan, Sompong Vongpunsawad & Yong Poovorawan. (2020) Towards the elimination of viral hepatitis in Thailand by the year 2030. Journal of Virus Eradication 6:3, pages 100003.
Crossref
Crossref
Maria Gabriella Verso, Claudio Costantino, Alessandro Marrella, Palmira Immordino, Francesco Vitale & Emanuele Amodio. (2020) Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up. Vaccines 8:3, pages 467.
Crossref
Crossref
Alicia M. Ritscher, Megan LeClair-Netzel, Nicholas J. Friedlander, Danielle N. Howard Stewart, Mallory Wagner, Nicole Kalscheur, Freddy Caldera & Mary S. Hayney. (2020) Cross-sectional study of hepatitis B antibody status in health care workers immunized as children at an academic medical center in Wisconsin. Vaccine 38:7, pages 1597-1600.
Crossref
Crossref
Arianna Marini, Yu Zhou, Yuanyuan Li, Iona J. Taylor, Darren B. Leneghan, Jing Jin, Marija Zaric, David Mekhaiel, Carole A. Long, Kazutoyo Miura & Sumi Biswas. (2019) A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response. Frontiers in Immunology 10.
Crossref
Crossref
Yu-Liang Zhao, Bi-Hua Han, Xin-Jiang Zhang, Lu-Lu Pan, Hai-Song Zhou, Zhao Gao, Zhi-Yong Hao, Zhi-Wei Wu, Tian-Li Ma, Feng Wang, Qi Li, Sheng-Li Bi & Jing-Chen Ma. (2019) Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infectious Diseases 19:1.
Crossref
Crossref
Pierre Van Damme, Marc Dionne, Geert Leroux‐Roels, Olivier Van Der Meeren, Emmanuel Di Paolo, Bruno Salaun, Pemmaraju Surya Kiran & Nicolas Folschweiller. (2019)
Persistence of
HB
sAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults
. Journal of Viral Hepatitis 26:9, pages 1066-1075.
Crossref
Crossref
Nawarat Posuwan, Viboonsak Vuthitanachot, Teeraporn Chinchai, Rujipat Wasitthankasem, Nasamon Wanlapakorn & Yong Poovorawan. (2019) Serological evidence of hepatitis A, B, and C virus infection in older adults in Khon Kaen, Thailand and the estimated rates of chronic hepatitis B and C virus infection in Thais, 2017. PeerJ 7, pages e7492.
Crossref
Crossref
Xueyan Wang, Qinyan Chen, Hai Li, Chao Wang, Liping Hu, Qingli Yang, Chuangchuang Ren, Huabing Liu, Zhigang Zheng, Tim J. Harrison & Zhong‐Liao Fang. (2019) Asymptomatic hepatitis B carriers who were vaccinated at birth. Journal of Medical Virology 91:8, pages 1489-1498.
Crossref
Crossref
Arundhathi Venkatasubramaniam, Rajan P. Adhikari, Thomas Kort, Grant C. Liao, Shawn Conley, Laura Abaandou, Shweta Kailasan, Yoshikuni Onodera, Subramaniam Krishnan, Didier M. Djagbare, Frederick W. Holtsberg, Hatice Karauzum & M. Javad Aman. (2019) TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens. Scientific Reports 9:1.
Crossref
Crossref
Seesai Yeesoonsang, Edward McNeil, Shama Virani, Surichai Bilheem, Chakrarat Pittayawonganon, Chuleeporn Jiraphongsa & Hutcha Sriplung. (2018) Trends in Incidence of Two Major Subtypes of Liver and Bile Duct Cancer: Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Southern Thailand, 1989-2030. Journal of Cancer Epidemiology 2018, pages 1-9.
Crossref
Crossref
Nawarat Posuwan, Arnond Vorayingyong, Vorapol Jaroonvanichkul, Rujipat Wasitthankasem, Nasamon Wanlapakorn, Sompong Vongpunsawad & Yong Poovorawan. (2018) Implementation of hepatitis B vaccine in high-risk young adults with waning immunity. PLOS ONE 13:8, pages e0202637.
Crossref
Crossref
Jodie Dionne-Odom, Basile Njei & Alan T.N. Tita. (2018) Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities. Clinical Therapeutics 40:8, pages 1255-1267.
Crossref
Crossref
Pierre Van Damme, John W. Ward, Daniel Shouval & Alessandro Zanetti. 2018. Plotkin's Vaccines. Plotkin's Vaccines
342
374.e17
.
John W. Ward & Pierre Van Damme. 2018. Hepatitis B Virus and Liver Disease. Hepatitis B Virus and Liver Disease
91
117
.
Kyeong Hun Lee, Kyu Seok Shim, In Seok Lim, Soo Ahn Chae, Sin Weon Yun, Na Mi Lee, Young Bae Choi & Dae Yong Yi. (2017) Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea. BMC Pediatrics 17:1.
Crossref
Crossref
Nancy F. Crum-Cianflone & Eva Sullivan. (2017) Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I. Infectious Diseases and Therapy 6:3, pages 303-331.
Crossref
Crossref
S. Hustache, L. Moyroud, L. Goirand & O. Epaulard. (2017) Hepatitis B vaccination status in an at-risk adult population: long-term immunity but insufficient coverage. European Journal of Clinical Microbiology & Infectious Diseases 36:8, pages 1483-1489.
Crossref
Crossref
Alessandro Zanetti, Maria Giuseppina Desole, Luisa Romanò, Antonio d'Alessandro, Michele Conversano, Giuseppe Ferrera, Maria Grazia Panico, Alberto Tomasi, Giorgio Zoppi, Massimo Zuliani, Stéphane Thomas, Benoît Soubeyrand, Cécile Eymin & Stephen Lockhart. (2017) Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10 years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy. Vaccine 35:32, pages 4034-4040.
Crossref
Crossref
Pierre Van Damme. (2016) Long-term Protection After Hepatitis B Vaccine. Journal of Infectious Diseases 214:1, pages 1-3.
Crossref
Crossref
Jiri Beran, Olivier Van Der Meeren, Maarten Leyssen & Priya D'silva. (2016) Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine. Vaccine 34:24, pages 2686-2691.
Crossref
Crossref
Olivier Van Der Meeren, Ulrich Behre & Priya Crasta. (2016) Immunity to hepatitis B persists in adolescents 15–16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. Vaccine 34:24, pages 2745-2749.
Crossref
Crossref
Parichat Yimnoi, Nawarat Posuwan, Nasamon Wanlapakorn, Pisit Tangkijvanich, Apiradee Theamboonlers, Sompong Vongpunsawad & Yong Poovorawan. (2016) A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization. Journal of Medical Virology 88:4, pages 664-673.
Crossref
Crossref
Nawarat Posuwan, Nasamon Wanlapakorn, Pattaratida Sa-nguanmoo, Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Viboonsak Vuthitanachot, Siriporn Sae-lao, Monthana Foonoi, Apinya Fakthongyoo, Jamorn Makaroon, Klaita Srisingh, Duangporn Asawarachun, Somchai Owatanapanich, Norra Wutthiratkowit, Kraisorn Tohtubtiang, Pornsak Yoocharoen, Sompong Vongpunsawad & Yong Poovorawan. (2016) The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation. PLOS ONE 11:3, pages e0150499.
Crossref
Crossref
Celine A. Hayden, Maria E. Fischer, Bryan L. Andrews, Hayley C. Chilton, Debra D. Turner, John H. Walker, Ian R. Tizard & John A. Howard. (2015) Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses. Vaccine 33:25, pages 2881-2886.
Crossref
Crossref
Xin Zheng, Xianlin Ye, Peng Du, Jinfeng Zeng, Weigang Zhu, Baocheng Yang, Chengyao Li & Jean-Pierre Allain. (2015) High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply. Transfusion 55:4, pages 890-897.
Crossref
Crossref
Noele P. Nelson, Denise J. Jamieson & Trudy V. Murphy. (2014) Prevention of Perinatal Hepatitis B Virus Transmission. Journal of the Pediatric Infectious Diseases Society 3:suppl_1, pages S7-S12.
Crossref
Crossref
Nancy F. Crum-CianfloneMark R. Wallace. (2014) Vaccination in HIV-Infected Adults. AIDS Patient Care and STDs 28:8, pages 397-410.
Crossref
Crossref